Literature DB >> 22135851

The paraoxonase 1, 2 and 3 in humans.

Marija Grdic Rajkovic1, Lada Rumora, Karmela Barisic.   

Abstract

The paraoxonase gene family in humans includes three members: PON1, PON2 and PON3. The products of those three genes are the following enzymes: paraoxonase 1 (PON1), paraoxonase 2 (PON2) and paraoxonase 3 (PON3). PON1 is mainly associated with a high density lipoprotein (HDL). A small amount of this enzyme is also bound to very low-density lipoprotein (VLDL) and postprandial chylomicrons. PON1 possess organophosphatase, arylesterase and lactonase activity and it hydrolyzes many different substrates. It is also known that PON1 may have antiatherogenic function. Compared to the PON1, PON2 and PON3 are much less studied and described. PON2 is ubiquitously expressed intracellular protein, while PON3 is bound to HDL, like PON1. The both enzymes possess antioxidant properties.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22135851     DOI: 10.11613/bm.2011.020

Source DB:  PubMed          Journal:  Biochem Med (Zagreb)        ISSN: 1330-0962            Impact factor:   2.313


  27 in total

Review 1.  Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles.

Authors:  Mike Mackness; Bharti Mackness
Journal:  Gene       Date:  2015-05-09       Impact factor: 3.688

2.  Visfatin, PON-1 Levels in Iraqi Hyperthyroidism Patient's with Dyslipidemia.

Authors:  Noorhan K Shafeeq
Journal:  Indian J Clin Biochem       Date:  2017-11-14

3.  Paraoxonase-1 Facilitates PRRSV Replication by Interacting with Viral Nonstructural Protein-9 and Inhibiting Type I Interferon Pathway.

Authors:  Lin Zhang; Yu Pan; Yunfei Xu; Wenli Zhang; Wenjie Ma; Yassein M Ibrahim; Gebremeskel Mamu Werid; He Zhang; Changyou Xia; Ping Wei; Hongyan Chen; Yue Wang
Journal:  Viruses       Date:  2022-05-31       Impact factor: 5.818

4.  Expression of PON1, PON2, PON3 and MPO Genes in Patients with Depressive Disorders.

Authors:  Katarzyna Bliźniewska-Kowalska; Piotr Gałecki; Kuan-Pin Su; Angelos Halaris; Janusz Szemraj; Małgorzata Gałecka
Journal:  J Clin Med       Date:  2022-06-09       Impact factor: 4.964

5.  Paraoxonase and arylesterase levels in autoimmune thyroid diseases.

Authors:  Hakan Korkmaz; Suzan Tabur; Mesut Ozkaya; Elif Oguz; Umut Elboga; Nurten Aksoy; Ersin Akarsu
Journal:  Redox Rep       Date:  2016-01-21       Impact factor: 4.412

6.  New prospects of mesenchymal stem cells for ameliorating temporal lobe epilepsy.

Authors:  Neveen A Salem; Marwa El-Shamarka; Yasser Khadrawy; Shaimaa El-Shebiney
Journal:  Inflammopharmacology       Date:  2018-02-22       Impact factor: 4.473

Review 7.  PON1 and Mediterranean Diet.

Authors:  José M Lou-Bonafonte; Clara Gabás-Rivera; María A Navarro; Jesús Osada
Journal:  Nutrients       Date:  2015-05-27       Impact factor: 5.717

Review 8.  Renal dopamine receptors, oxidative stress, and hypertension.

Authors:  Santiago Cuevas; Van Anthony Villar; Pedro A Jose; Ines Armando
Journal:  Int J Mol Sci       Date:  2013-08-27       Impact factor: 5.923

9.  Quantitative high-throughput profiling of snake venom gland transcriptomes and proteomes (Ovophis okinavensis and Protobothrops flavoviridis).

Authors:  Steven D Aird; Yutaka Watanabe; Alejandro Villar-Briones; Michael C Roy; Kouki Terada; Alexander S Mikheyev
Journal:  BMC Genomics       Date:  2013-11-14       Impact factor: 3.969

10.  Paraoxonase 1 activity and phenotype distribution in premenopausal and postmenopausal women.

Authors:  Dražan Butorac; Ivana Celap; Sanja Kačkov; Vera Robić; Tomislav Miletić; Zlata Flegar Meštrić; Andrea Hulina; Krunoslav Kuna; Tihana Žanić Grubišić; Marija Grdić Rajković
Journal:  Biochem Med (Zagreb)       Date:  2014-06-15       Impact factor: 2.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.